Nicolas Arcuri, DPM
Foot & Ankle Surgery · Jackson, TNNPI 1962740696
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Johnson & Johnson at 33.2% of the total. Reporting peaked in 2022 at $9,245 and has fallen 80.5% since, to $1,801 in 2025.
Across 170 payments — averaging $157.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$9K
- Medical Device Business Services, Inc.$8K
- Gentleman Orthopedic Solutions$3K
- Crossroads Extremity Systems, LLC$2K
- Osiris Therapeutics Inc.$2K
- Smith+Nephew$1K
- plus $2K from 28 others
What the payments were for
- Consulting fees$15,98860%
- Speaking & faculty fees$1,5006%
- Travel & lodging$2,5089%
- Food & beverage$4,30316%
- Education$2,5179%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $8,890 |
| Medical Device Business Services, Inc. | 17 | $7,847 |
| Gentleman Orthopedic Solutions | 4 | $2,711 |
| Crossroads Extremity Systems, LLC | 2 | $2,400 |
| Osiris Therapeutics Inc. | 3 | $1,597 |
| Smith+Nephew | 44 | $1,033 |
| Bioventus LLC | 10 | $243 |
| Stryker(2 entities) | 4 | $204 |
| Organogenesis Inc. | 9 | $200 |
| Amgen(2 entities) | 10 | $173 |
| Orthofix Medical, Inc. | 3 | $159 |
| Paratek Pharmaceuticals, Inc. | 9 | $153 |
| Treace Medical Concepts, Inc. | 5 | $115 |
| Polymedics Innovations Inc. | 2 | $112 |
| Pacira Pharmaceuticals Incorporated | 4 | $98 |
| Hypermed Imaging Inc. | 1 | $96 |
| Kerecis Limited | 2 | $93 |
| Nevro Corp. | 4 | $73 |
| Bone Support Inc. | 2 | $71 |
| Paragon 28, Inc. | 2 | $69 |
| Kowa Pharmaceuticals America, Inc. | 3 | $63 |
| Convatec Inc. | 3 | $59 |
| Triad Life Sciences Inc. | 3 | $54 |
| Progenacare Global, LLC | 1 | $41 |
| Averitas Pharma Inc. | 2 | $40 |
| Reprise Biomedical, Inc. | 2 | $30 |
| AbbVie | 1 | $28 |
| Nabriva Therapeutics, PLC | 2 | $27 |
| Solventum Corporation | 1 | $27 |
| Globus Medical | 1 | $25 |
| Advanced Oxygen Therapy Inc. | 2 | $24 |
| Vertex | 1 | $21 |
| Stimlabs LLC | 1 | $21 |
| GRT US Holding, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOBAND$9,481
- Medical Implant$2,400
- Stravix$1,774
- Grafix$1,637
- NA$935
- TFN-Advance$151
- Grafix PL PRIME$137
- MINIBUNION$128
- TrueLok$117
- TL-HEX TRUELOK HEXAPOD SYSTEM$117
How this compares
$26,816 in reported general payments places this provider in the 85th percentile of 145 foot & ankle surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $4,468 |
| Diclofenac Sodium | 79 | $1,195 |
| Clotrimazole | 34 | $555 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $409 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 72 | $391 |
| Cephalexin | 75 | $370 |
| Gabapentin | 57 | $258 |
| Meloxicam | 106 | $251 |
| Clindamycin Hcl | 17 | $154 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $145 |
| Mupirocin | 13 | $118 |
| Doxycycline Hyclate | 12 | $115 |
| Levofloxacin | 27 | $90 |
| Triamcinolone Acetonide | 23 | $89 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,033 | $4,46813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 145 foot & ankle surgery providers in Tennessee.
Other foot & ankle surgery in Jackson
- Sebastien DemoinyMorristown$210K
- Robert ThompsonMurfreesboro$205K
- Bhekumuzi KhumaloUnion City$201K
- Walter ButlerMemphis$191K
- Chad WebsterCordova$185K
- Christian SmithCordova$153K
- Frank OgnibeneMemphis$148K
- Garnett MurphyGermantown$130K
- Clayton BettinMemphis$89K
- David RichardsonGermantown$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.